Noninvasive diagnosis of incomplete endovascular aneurysm repair: D-dimer assay to detect type I endoleaks and nonshrinking aneurysms

Journal of Endovascular Therapy

Volumn 9, Issue 1, 2002, Pages 90-97

  Serino, Francesco ^a   Abeni, Damiano ^a   Galvagni, Elisabetta ^a   Sardella, Savino G ^a   Scuro, Alberto ^a   Ferrari, Mauro ^a   Ciarafoni, Iole ^a   Silvestri, Lorena ^a   Fusco, Angelo ^a  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

Abdominal aortic aneurysm; Aneurysm sac diameter; Diagnostic test; Endovascular grafts; Sac enlargement

Indexed keywords

D DIMER; FIBRIN DEGRADATION PRODUCT;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; ANEURYSM; ANEURYSM SURGERY; ARTICLE; BLOOD VESSEL GRAFT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST; DISEASE MARKER; ENDOLEAK; ENDOVASCULAR SURGERY; FEMALE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NONSHRINKING ANEURYSM; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TURBIDIMETRY; VENOUS BLOOD;

ANGIOGRAPHY; AORTIC ANEURYSM, ABDOMINAL; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; MALE; POSTOPERATIVE COMPLICATIONS; PROBABILITY; PROSTHESIS FAILURE; RADIOIMMUNOASSAY; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC;

EID: 0036204386     PISSN: 15266028     EISSN: None     Source Type: Journal    
DOI: 10.1583/1545-1550(2002)009<0090:NDOIEA>2.0.CO;2     Document Type: Article

References (29)

1. Endoleakage after stent-graft treatment of abdominal aneurysm: Implications on pressure and imaging - An in vitro study
2. Endoleak, endotension, and sac morphology after endovascular aneurysm repair: EUROSTAR and Liverpool data
3. Endoleak as a predictor of outcome after endovascular aneurysm repair: AneuRx multicenter clinical trial
4. Aortic aneurysm size and graft behavior after endovascular stent-grafting: Clinical experiences and observations over 3 years
5. Duplex ultrasound scanning versus computed tomographic angiography for postoperative evaluation of endovascular abdominal aortic aneurysm repair
6. Follow-up evaluation of endoluminally treated abdominal aortic aneurysms with duplex ultra-sonography: Validation with computed tomography
7. Magnetic resonance imaging and MR angiography of endoluminally treated abdominal aortic aneurysms
8. An overview of fibrinolysis
9. D-dimer testing in suspected venous thromboembolism: An update
10. Markers of plasma coagulation and fibrinolysis after acute deep venous thrombosis
11. Investigations into the clinical utility of latex D-dimer in the diagnosis of deep venous thrombosis
12. Value of D-dimer measurement in arterial thrombosis and after angioplasty
13. Combination of a clinical risk assessment score and rapid whole blood D-dimer testing in the diagnosis of deep vein thrombosis in symptomatic patients
14. The value of rapid D-dimer testing combined with structured clinical evaluation for the diagnosis of deep vein thrombosis
15. Relationship between elevated plasma levels of crosslinked fibrin degradation products (XL-FDP) and the clinical presentation of patients with myocardial infarction
16. Utility of D-dimer measurement in deep venous thrombosis
17. D-dimer and TAT measurement in patients with deep venous thrombosis: Utility in diagnosis and judgment of anticoagulant treatment effectivessness
18. Endoleak as a complication of endoluminal grafting of abdominal aortic aneurysms: Classification, incidence, diagnosis, and management
19. No adjustments are needed for multiple comparisons
20. Fundamentals of epidemiologic data analysis
21. Multiple comparisons and related issues in the interpretation of epidemiologic data
22. Endograft surveillance: A priority for long-term device performance
23. Effects of asymptomatic abdominal aortic aneurysm on the soluble coagulation system, platelet count and platelet activation
24. Coagulation and fibrinolysis after open infrarenal abdominal aortic aneurysm repair in a long-term perspective
25. An activated state of blood coagulation and fibrinolysis in patients with abdominal aortic aneurysm
26. Haemostatic factors, atherosclerosis and risk of abdominal aortic aneurysm
27. Expanded polytetrafluoroethylene (ePTFE) vascular graft loses its thrombogenicity six months after implantation